BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
BEGIN:VEVENT
UID:434@biocityturku.fi
DTSTART;TZID=Europe/Helsinki:20200130T120000
DTEND;TZID=Europe/Helsinki:20200130T130000
DTSTAMP:20231013T063132Z
URL:https://biocityturku.fi/events/frontiers-of-science-prof-philip-calder
 /
SUMMARY:Frontiers of Science: Omega-3 polyunsaturated fatty acids and infla
 mmatory processes: from the membrane to the nucleus and from the lab bench
  to the bedside
DESCRIPTION:Prof. Philip Calder\, University of Southampton\, UK\nOmega-3 p
 olyunsaturated fatty acids and inflammatory processes: from the membrane t
 o the nucleus and from the lab bench to the bedside\n\nHost: Kirsi Laitine
 n (kirsi.laitinen@utu.fi)\n\n&nbsp\;\n\nProfessor Philip Calder is Head of
  Human Development &amp\; Health and Professor of Nutritional Immunology w
 ithin Medicine at the University of Southampton\, Southampton\, UK. He ha
 s broad research interests in nutritional modulation of immunity\, inflamm
 ation and cardiometabolic disease risk. Much of his work has been devoted 
 to exploring the metabolism and functionality of fatty acids with an empha
 sis on the roles of omega-3 fatty acids. He has over 500 scientific public
 ations and he is listed as a Highly Cited Researcher. He has been awarded 
 several national and international research awards and he has served on ma
 ny committees of professional societies and Editorial Boards of journals i
 n the nutrition\, clinical science and lipidology fields. He is a Fellow o
 f the Royal Society for Biology\, the Association for Nutrition\, the High
 er Education Academy and International Society for the Study of Fatty Acid
 s and Lipids.\n\nFor further details\, please see: https://www.southampton
 .ac.uk/medicine/about/staff/pcc.page\n\nIn his presentation prof Calder wi
 ll address the role of inflammation in common human diseases\, the mechani
 sms by which omega-3 fatty acids reduce inflammation\, and the use of omeg
 a-3 fatty acids in specific patient groups.\n\nReferences\nOstermann\, A.I
 .\, West\, A.L.\, Schoenfeld\, K.\, Browning\, L.M.\, Walker\, C.G.\, Jebb
 \, S.A.\, Calder\, P.C. and Schebb\, N.H.\, Plasma oxylipins respond in a
  linear dose-response manner with increased intake of EPA and DHA: results
  from a randomized controlled trial in healthy humans. American Journal of
  Clinical Nutrition\, 109\, 2019\, 1251-1263.\n\nWest\, A.L.\, Kindberg\, 
 G.M.\, Hustvedt\, S.O.\, and Calder\, P.C.\, A novel self-micro-emulsifyi
 ng delivery system enhances enrichment of eicosapentaenoic acid and docosa
 hexaenoic acid after single and repeated dosing in healthy adults in a ran
 domized trial. Journal of Nutrition\, 148\, 2018\, 1704-1715.\n\nCalder\, 
 P.C.\, Laviano\, A.\, Lonnqvist\, F.\, Muscaritoli\, M.\, Öhlander\, M. a
 nd Schols\, A.\, Targeted medical nutrition for cachexia in chronic obstru
 ctive pulmonary disease: a randomized\, controlled trial. Journal of Cache
 xia Sarcopenia and Muscle\, 9\, 2018\, 28-40.\n\nInnes\, J.K. and Calder\
 , P.C.\, The differential effects of eicosapentaenoic acid and docosahexae
 noic acid on cardiometabolic risk factors: A systematic review. Internatio
 nal Journal of Molecular Sciences\, 19\, 2018\, 532.\n\nJeffery\, L.\, Fis
 k\, H.L.\, Calder\, P.C.\, Filer\, A.\, Raza\, K.\, Buckley\, C.D.\, McIn
 nes\, I.\, Taylor\, P.C. and Fisher\, B.A.\, Plasma levels of eicosapentae
 noic acid are associated with anti-TNF responsiveness in rheumatoid arthri
 tis and inhibit the etanercept-driven rise in Th17 cell differentiation in
  vitro. Journal of Rheumatology\, 44\, 2017\, 748-756.\n\nWest\, A.L.\, Bu
 rdge\, G.C. and Calder\, P.C.\, Lipid structure does not modify incorpora
 tion of EPA and DHA into blood lipids in healthy adults: a randomised-cont
 rolled trial. British Journal of Nutrition\, 116\, 2016\, 788-797.\n\nDel 
 Bas\, J.M.\, Caimari\, A.\, Rodriguez-Naranjo\, M.I.\, Childs\, C.E.\, Par
 as Chavez\, C.\, West\, A.L.\, Miles\, E.A.\, Arola\, L. and Calder\, P.C
 .\, Impairment of lysophospholipid metabolism in obesity: altered plasma p
 rofile and desensitization to the modulatory properties of n-3 polyunsatur
 ated fatty acids in a randomized controlled trial. American Journal of Cli
 nical Nutrition\, 104\, 2016\, 266-279.
CATEGORIES:BiocityTurku events
LOCATION:#_LOCATIONNAME\, #_LOCATIONFULLLINE\, #_LOCATIONCOUNTRY
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=#_LOCATIONFULLLINE\, #_LOCA
 TIONCOUNTRY;X-APPLE-RADIUS=100;X-TITLE=#_LOCATIONNAME:geo:0,0
END:VEVENT
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
X-LIC-LOCATION:Europe/Helsinki
BEGIN:STANDARD
DTSTART:20191027T030000
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
END:STANDARD
END:VTIMEZONE
END:VCALENDAR